Production (Stage)
Sana Biotechnology, Inc.
SANA
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.65% | 18.11% | -19.15% | 53.21% | -21.97% |
| Total Depreciation and Amortization | -4.02% | -6.29% | 4.16% | 3.98% | -11.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 228.81% | -240.37% | 130.30% | -131.81% | 110.29% |
| Change in Net Operating Assets | -354.23% | 1,341.57% | -114.64% | 131.48% | -172.83% |
| Cash from Operations | -3.17% | 8.99% | 11.48% | 10.80% | -26.31% |
| Capital Expenditure | 68.81% | 89.35% | 68.65% | 17.60% | -12.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -65.31% | 3.61% | 143.02% | 130.75% | -309.10% |
| Cash from Investing | -64.74% | 12.72% | 618.03% | 107.53% | -604.43% |
| Total Debt Issued | -- | -132.56% | -97.75% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.23% | -63.40% | -36.31% | -98.39% | 10,749.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 52.72% | -69.12% | -80.41% | -94.30% | 10,749.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,551.23% | 107.16% | 81.09% | -196.69% | 224.64% |